Calcipotriol/Betamethason Dermapharm 50 µg/g - 0,5 mg/g ointm.

国家: 比利时

语言: 英文

来源: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

现在购买

有效成分:

Calcipotriol Monohydrate 0,052 mg/g - Eq. Calcipotriol 0,05 mg/g; Betamethasone Dipropionate 0,643 mg/g - Eq. Betamethasone 0,5 mg/g

可用日期:

Dermapharm AG

ATC代码:

D05AX52

INN(国际名称):

Calcipotriol Monohydrate; Betamethasone Dipropionate

剂量:

50 µg/g - 0,5 mg/g

药物剂型:

Ointment

组成:

Calcipotriol Monohydrate 0.052 mg/g; Betamethasone Dipropionate 0.643 mg/g

给药途径:

Cutaneous use

治疗领域:

Calcipotriol, Combinations

產品總結:

CTI code: 543217-07 - Pack size: 100 g (2 x 50 g) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-08 - Pack size: 120 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-09 - Pack size: 120 g (2 x 60 g) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-03 - Pack size: 35 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-04 - Pack size: 50 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-05 - Pack size: 60 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-06 - Pack size: 100 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-01 - Pack size: 15 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 543217-02 - Pack size: 30 g - Commercialisation status: NO - Delivery mode: Medical prescription

授权状态:

Commercialised: No

授权日期:

2019-07-02

其他语言的文件

资料单张 资料单张 德文 01-07-2019
资料单张 资料单张 法文 01-07-2019
产品特点 产品特点 法文 01-07-2019
资料单张 资料单张 荷兰文 23-02-2021
产品特点 产品特点 荷兰文 01-07-2019